We are live on ! Find out more
Marshall Wace

Marshall Wace Portfolio holdings

AUM $100B
1-Year Est. Return 35.1%
This Fund
S&P 500
This Quarter Est. Return
+22.23%
1 Year Est. Return
+35.1%
3 Year Est. Return
+111.04%
5 Year Est. Return
+146.93%
10 Year Est. Return
+631.22%
AUM
$18.5B
AUM Growth
+$2.83B
Cap. Flow
+$342M
Cap. Flow %
1.85%
Top 10 Hldgs %
16.55%
Holding
2,427
New
891
Increased
366
Reduced
546
Closed
599

Top Buys

Rank Stock Value
1
TMO icon
Thermo Fisher Scientific
TMO
+$163M
2
CCL icon
Carnival Corporation Ltd
CCL
+$137M
3
RGEN icon
Repligen
RGEN
+$104M
4
BIIB icon
Biogen
BIIB
+$104M
5
ZTS icon
Zoetis
ZTS
+$91.9M

Sector Composition

Rank Sector Weight
1 Healthcare 28.24%
2 Consumer Discretionary 12.89%
3 Financials 10.77%
4 Technology 9.62%
5 Industrials 4.73%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
TIG
1776
DELISTED
Trean Insurance Group, Inc. Common Stock
TIG
$134K ﹤0.01%
+10,230
New +$136K
TRQ
1777
DELISTED
Turquoise Hill Resources Ltd
TRQ
$132K ﹤0.01%
10,642
-34,716
-77% -$336K
XLE icon
1778
State Street Energy Select Sector SPDR ETF
XLE
$38.8B
$130K ﹤0.01%
6,840
-212,016
-97% -$3.65M
ICL icon
1779
ICL Group
ICL
$6.65B
$129K ﹤0.01%
+25,292
New +$106K
CNR
1780
Core Natural Resources Inc
CNR
$4.16B
$129K ﹤0.01%
17,841
-84,570
-83% -$443K
RLGT icon
1781
Radiant Logistics
RLGT
$415M
$127K ﹤0.01%
+21,930
New +$123K
NFH
1782
DELISTED
New Frontier Health Corporation Ordinary Shares
NFH
$126K ﹤0.01%
+14,580
New +$126K
TCRT icon
1783
Alaunos Therapeutics
TCRT
$4.71M
$123K ﹤0.01%
325
-28
-8% -$11.1K
DBVT
1784
DBV Technologies
DBVT
$823M
$120K ﹤0.01%
4,593
SUP
1785
DELISTED
Superior Industries International
SUP
$120K ﹤0.01%
+29,284
New +$91.2K
FPI
1786
Farmland Partners
FPI
$420M
$114K ﹤0.01%
13,142
-114,596
-90% -$868K
FREE
1787
DELISTED
Whole Earth Brands, Inc. Class A Common Stock
FREE
$114K ﹤0.01%
+10,430
New +$95.4K
ARLP icon
1788
Alliance Resource Partners
ARLP
$3.3B
$113K ﹤0.01%
+25,136
New +$96.2K
ARAV
1789
DELISTED
Aravive, Inc. Common Stock
ARAV
$111K ﹤0.01%
19,764
-21,577
-52% -$118K
DAKT icon
1790
Daktronics
DAKT
$956M
$108K ﹤0.01%
23,072
-27,826
-55% -$122K
SSL icon
1791
Sasol
SSL
$7.34B
$108K ﹤0.01%
+12,210
New +$91.5K
XONE
1792
DELISTED
The ExOne Company
XONE
$104K ﹤0.01%
+10,983
New +$125K
CSPR
1793
DELISTED
Casper Sleep Inc.
CSPR
$102K ﹤0.01%
16,551
+3,095
+23% +$21.2K
ONCS
1794
DELISTED
OncoSec Medical Incorporated
ONCS
$102K ﹤0.01%
+718
New +$76.6K
VATE icon
1795
INNOVATE Corp
VATE
$116M
$96K ﹤0.01%
+2,954
New +$82.2K
MMX
1796
DELISTED
Maverix Metals Inc. Common Shares
MMX
$96K ﹤0.01%
17,400
-22,871
-57% -$120K
VRAY
1797
DELISTED
ViewRay, Inc.
VRAY
$94K ﹤0.01%
+24,481
New +$86.6K
WKEY
1798
WISeKey
WKEY
$71.3M
$92K ﹤0.01%
+2,588
New +$77.4K
TGS icon
1799
Transportadora de Gas del Sur
TGS
$4.59B
$89K ﹤0.01%
17,115
-70,876
-81% -$367K
JFIN
1800
Jiayin Group
JFIN
$113M
$82K ﹤0.01%
+26,813
New +$84.8K

Similar funds

Marshall Wace's Q4 2020 Portfolio in Review

As of Q4 2020, Marshall Wace held 2,427 positions worth $18.5B, up 18% from $15.6B the previous quarter. Its ten largest holdings account for 17% of the portfolio.

Marshall Wace's Q4 2020 filing shows 891 new, 366 increased, 546 reduced and 599 closed positions. Its largest new stake was Natera: 911,254 shares worth $90.7M. The largest sale was Alphabet (Google) Class A, an estimated $173M.

By sector, the portfolio is most concentrated in Healthcare at 28% of assets, up from 24% a quarter earlier, followed by Consumer Discretionary and Financials.

  • Marshall Wace's largest Q4 2020 buy was Natera: 911,254 shares worth $90.7M.
  • Marshall Wace added most to Thermo Fisher Scientific in Q4 2020, an estimated $163M increase.
  • Marshall Wace's biggest Q4 2020 reduction was Alphabet (Google) Class A, cutting an estimated $173M.
  • Marshall Wace fully exited FedEx in Q4 2020, selling an estimated $69.6M.
  • Marshall Wace's ten largest holdings make up 17% of its $18.5B portfolio in Q4 2020.
  • Marshall Wace opened 891 new positions and closed 599 in Q4 2020.
  • Marshall Wace's portfolio value rose 18% quarter-over-quarter to $18.5B.

Based on Marshall Wace's 13F filing for Q4 2020, filed 16 Feb 2021.